http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8679c166ab9e869a9ab36b1322447d42
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Montuenga |
| name | Luis M. Montuenga Luis M Montuenga |
| given-name | Luis M. Luis M |
| organization-name | Authors' Affiliations: Departments of 1Oncology, 2Pathology, and 3Thoracic Surgery, Clínica Universidad de Navarra; 4Division of Oncology, Center for Applied Medical Research (CIMA), Pamplona, Spain; Departments of 5Thoracic/Head and Neck Medical Oncology and 6Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas Center of Applied Medical Research (CIMA) and Schools of Sciences and Medicine, University of Navarra , Pamplona, Spain; Navarra Institute for Health Research (IdiSNA) , Pamplona, Spain; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC) , Madrid, Spain 4IDISNA and Program in Solid Tumors and Biomarkers, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; 5Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain. Division of Oncology Center for Applied Medical Research (CIMA) University of Navarra Pamplona Spain; Department of Histology and Pathology School of Medicine University of Navarra Pamplona Spain Biomarkers Laboratory, and Division of Oncology, Center for Applied Medical Research, 31008 Pamplona, Spain; Cell and Cancer Biology Department, Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Department of Histology and Pathology, University of Navarra, Pamplona, Spain; and Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 1Division of Oncology, Center for Applied Medical Research, Pamplona, Spain;; 3Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain; and Biomarkers Laboratory, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, 31008 Pamplona, Spain Department of Histology and Pathology, Schools of Sciences and Medicine, University of Navarra, E-31080 Pamplona, Spain María J. Pajares, Jackeline Agorreta, Marta Larrayoz, Teresa Ezponda, Isabel Zudaire, Wenceslao Torre, María D. Lozano, Ruben Pio, and Luis M. Montuenga, Center for Applied Medical Research (CIMA) and Clinica Universidad de Navarra (CUN), University of Navarra, Pamplona, Spain; Aurélien Vesin, Elisabeth Brambilla, Christian Brambilla, and Jean-Francois Timsit, Institut Albert Bonniot, Centre Hospitalier Universitaire Albert Michallon, Institut National de la Santé et de la Recherche Médicale (INSERM)... Program in Solid Tumors, Center for Applied Medical Research (CIMA), CIBERONC, and Navarra’s Health Research Institute (IDISNA), Pamplona, Spain; Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain 2Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain.; 3Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA) and Navarra's Health Research Institute (IDISNA), Pamplona, Spain. Juan Sandoval, Jesus Mendez-Gonzalez, F. Javier Carmona, Sergi Sayols, Sebastian Moran, Holger Heyn, Miguel Vizoso, Antonio Gomez, Montse Sanchez-Cespedes, and Manel Esteller, Bellvitge Biomedical Research Institute; Josefina Mora, Hospital de la Santa Creu i Sant Pau; Manel Esteller, University of Barcelona and Institucio Catalana de Recerca i Estudis Avançats, Barcelona; Miquel Taron and Rafael Rosell, Catalan Institute of Oncology, Badalona, Catalonia; Marina Pollan, Instituto de Salud Carlos III,... Clínica Universidad de Navarra, Pamplona, Spain Institute of Health Research of Navarra, Pamplona, Spain 2; Department of Solid Tumors, Center for Applied Medical Research, University of Navarra, Pamplona, Spain 5; Department of Pathology, Anatomy and Physiology, University of Navarra and CIBERONC, Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain 6 Program in Solid Tumors and Biomarkers, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain 1Division of Oncology, Center for Applied Medical Research, Clínica Universitaria/Facultad de Medicina,; 4Department of Histology and Pathology, University of Navarra, c/Irunlarrea, Pamplona, Spain, and Oncology Division, Center for Applied Medical Research (CIMA), University of Navarra, Avda. Pio XII, 55, Pamplona, 31008, Spain. Fax: +34 948 194714; Tel: +34 948 194700 ext. 1000; Department of Histology and Pathology, Schools of Medicine and Sciences, University of Navarra, Irunlarrea 1, Pamplona, 31008, Spain Department of Histology and Pathology (L.M.M.) University of Navarra 31080 Pamplona, Spain Solid Tumour and Biomarkers Programme, Centre for Applied Medical Research and Department of Histology and Pathology University of Navarra Pamplona Spain Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Health Research Institute (IDISNA), University of Navarra, Pamplona, Spain; Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain 1Division of Oncology and Departments of; 4Histology and Pathology, and Program in Solid Tumors and Biomarkers Center for Applied Medical Research (CIMA) University of Navarra Pamplona 31009 Spain; Department of Histology and Pathology University of Navarra Pamplona 31009 Spain; Respiratory Tract Tumors Group Idisna Pamplona 31000 Spain; Respiratory Tract Tumors Program CIBERONC Madrid 28013 Spain Program in Solid Tumors and Biomarkers, Center for Applied Medical Research; Department of Histology and Pathology, and Center for Applied Medical Research (CIMA) University of Navarra Spain; CIBERONC Madrid Spain; IDISNA Pamplona Spain; Department of Pathology, Anatomy and Physiology School of Medicine University of Navarra Pamplona Spain Authors' Affiliations: 1Division of Oncology, Center for Applied Medical Research; 2Department of Biochemistry, School of Sciences, University of Navarra; 3Department of Pulmonary Medicine, School of Medicine, Clinica Universidad de Navarra; 4Department of Histology and Pathology, School of Medicine, University of Navarra; 5Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain; 6Medizinische Klinik m.S. Infektologie und Pulmologie (Arbeitsbereich Pneumologische Onkologie) CCM, Charité-Universitätsmedizin Berlin, Germany; and 7Medical Oncology Department, Catalan Institute of Oncology-IDIBELL, Barcelona, Spain; Authors' Affiliations: 1Division of Oncology, Center for Applied Medical Research; 2Department of Biochemistry, School of Sciences, University of Navarra; 3Department of Pulmonary Medicine, School of Medicine, Clinica Universidad de Navarra; 4Department of Histology and Pathology, School of Medicine, University of Navarra; 5Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain; 6Medizinische Klinik m.S. Infektologie und Pulmologie (Arbeitsbereich Pneumologische Onkologie) CCM, Charité-Universitätsmedizin Berlin, Germany; and 7Medical Oncology Department, Catalan Institute of Oncology-IDIBELL, Barcelona, Spain Authors' Affiliations: 1Genes and Cancer Group, Cancer Epigenetics and Biology Program (PEBC); 2Translational Research Laboratory, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona; 3Instituto de Biomedicina de Sevilla (IBiS), 4Department of Pathology, Hospital Universitario Virgen del Rocío, Consejo Superior de Investigaciones Cientificas (CSIC), Universidad de Sevilla, Seville; 5Division of Oncology, Centro para la Investigación Medica Aplicada (CIMA), University of Navarre, Pamplona, Spain; 6MRC-Holland, Amsterdam, the Netherlands; and 7Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan Department of Histology and Pathology, University of Navarra, Pamplona, Spain; Department of Cell and Cancer Biology, National Cancer Institute, Bethesda, Maryland Authors' Affiliations: 1Oncology Division, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona; 2Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain; 3Nuffield Department of Clinical Laboratory Sciences; 4Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital; 5Department of Medical Oncology, University of Oxford, The Churchill Hospital, Oxford, United Kingdom; 6Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Jinan, China; and 7Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy 1Oncology Division, Center for Applied Medical Research; Departments of; 6Histology and Pathology, 1University of Navarra, Center for Applied Medical Research (CIMA), Program in Solid Tumors and Biomarkers, Pamplona, Spain.; 2Navarra's Health Research Institute (IdiSNA), Pamplona, Spain.; 3Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; 6University of Navarra, School of Medicine, Department of Histology and Pathology, Pamplona, Spain. Program in Solid Tumours, CIMA Pamplona Spain; Department of Histology and Pathology, School of Medicine University of Navarra Pamplona Spain; Navarra Health Research Institute (IDISNA) Pamplona Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain *Division of Oncology, Center for Applied Medical Research,; †Department of Histology and Pathology, and Authors' Affiliations: 1Adhesion and Metastasis Laboratory, 2Biomarkers Laboratory, Division of Oncology, Center for Applied Biomedical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain; and 3National Heart and Lung Institute, Imperial College London, London, United Kingdom *Division of Oncology, Center for Applied Medical Research, University of Navarra, Pamplona 31008, Spain;; ¶Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona 31008, Spain Authors' Affiliations: 1Oncology Division, Center for Applied Medical Research, Departments of 2Pathology, 3Oncology, and 4Thoracic Surgery, Clínica Universidad de Navarra, and Departments of 5Histology and Pathology and 6Biochemistry, Schools of Medicine and Sciences, University of Navarra, Pamplona, Spain; Authors' Affiliations: 1Oncology Division, Center for Applied Medical Research, Departments of 2Pathology, 3Oncology, and 4Thoracic Surgery, Clínica Universidad de Navarra, and Departments of 5Histology and Pathology and 6Biochemistry, Schools of Medicine and Sciences, University of Navarra, Pamplona, Spain Program in Solid Tumors Center for Applied Medical Research (CIMA) Pamplona Spain; Department of Pathology, Anatomy and Physiology School of Medicine University of Navarra Pamplona Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain; Navarra Health Research Institute (IDISNA) Pamplona Spain Division of Oncology Center for Applied Medical Research Pamplona Spain; Department of Histology and Pathology School of Medicine University of Navarra Pamplona Spain 2Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; 3Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain.; 4Program of Solid Tumors, Center for Applied Medical Research (CIMA), Pamplona, Spain. University of Navarra 1 Department of Histology and Pathology , Faculty of Medicine , , E-31080 Pamplona, Spain Programa de Patogénesis de Tumores Sólidos, Laboratorio de Biomarcadores, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Grupo RTICC RD12/0036/0040, Pamplona, España; Departamentos de Histología y Anatomía Patológica, Facultades de Medicina y Ciencias, Universidad de Navarra, Pamplona, España. Center for Applied Medical Research, Program in Solid Tumors and Biomarkers, Pamplona, Spain; IdiSNA (Navarra Institute for Health Research), Pamplona, Spain; CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Spain; Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Spain Department of Cell and Cancer Biology, National Cancer Institute, Medicine Branch, Rockville, Maryland 20850 Department of Cell and Cancer Biology (A.M., L.M.M., R.P., F.C.), National Cancer Institute, NIH, Bethesda, Maryland 20892 Authors' Affiliations: 1Division of Oncology, Center for Applied Medical Research (CIMA); Departments of 2Histology and Pathology and 3Biochemistry and Genetics, Schools of Science and Medicine, University of Navarra, Pamplona; and 4CEIT and TECNUN, University of Navarra, San Sebastian, Spain; Authors' Affiliations: 1Division of Oncology, Center for Applied Medical Research (CIMA); Departments of 2Histology and Pathology and 3Biochemistry and Genetics, Schools of Science and Medicine, University of Navarra, Pamplona; and 4CEIT and TECNUN, University of Navarra, San Sebastian, Spain 10Program in Solid Tumors, Center for Applied Medical Research Institution (CIMA), University of Navarra, Pamplona, Spain.; 11Centro de Investigación Biomedica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Navarra, Spain; IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain 7CIMA and Clinica Universidad de Navarra, Pamplona, Spain.; 8Centro de Investigación Biomédica en red de Oncología CIBERONC, Madrid, Spain. |
Incoming Links
Total number of triples: 191.